机器人对比开腹胰十二指肠切除术:降低胰瘘率与全面费用分析
该回顾性队列研究纳入2017至2023年日本高容量中心的193例壶腹周围肿瘤患者,经倾向性评分匹配后各60例比较机器人(RPD)与开腹(OPD)胰十二指肠切除术。RPD组临床相关胰瘘(CR-PF)率显著低于OPD组(10% vs 33.3%,p=0.003),住院时间更短(15天 vs 22.5天,p<0.001),尽管手术时间更长(633 vs 395分钟,p<0.001),总住院费用两组相当。结论支持RPD在壶腹周围肿瘤治疗中的可行性与潜在获益。
要点
- RPD组临床相关胰瘘率显著低于OPD组(10% vs 33.3%,p=0.003)。
- RPD组住院时间显著短于OPD组(15天 vs 22.5天,p<0.001)。
- RPD手术时间更长但总住院费用与OPD相当。
核心结论
- RPD可显著降低临床相关胰瘘率并缩短住院时间,且不增加总住院费用,支持其在壶腹周围肿瘤治疗中的可行性与潜在获益。
研究设计与样本
- 回顾性队列研究,2017至2023年日本高容量转诊中心纳入193例壶腹周围肿瘤患者,RPD组81例、OPD组112例,经倾向性评分匹配后两组各60例。
主要发现
- RPD组临床相关胰瘘率为10%,显著低于OPD组的33.3%(p=0.003)。
- RPD组住院时间为15天,显著短于OPD组的22.5天(p<0.001)。
- RPD组手术时间633分钟,显著长于OPD组的395分钟(p<0.001)。
- 两组总住院费用相当,RPD较高的手术费用被减少的术后并发症和缩短的住院时间所抵消。
临床怎么用
- 在具备机器人手术条件的中心,RPD可作为壶腹周围肿瘤胰十二指肠切除术的可行选择,有助于降低临床相关胰瘘率并缩短住院时间。
局限性
- 本研究为单中心回顾性队列研究,样本量有限,结论仍需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic pancreaticoduodenectomy (RPD) has emerged as a promising surgical approach for the treatment of periampullary neoplasms, offering the potential benefits of minimally invasive surgery. However, the impact of RPD on clinically relevant pancreatic fistula (CR-PF) rates and overall costs compared to open pancreaticoduodenectomy (OPD) remains unclear, limiting its widespread adoption. METHODS: This retrospective cohort study was conducted at a high-volume Japanese referral center from 2017 to 2023. A total of 193 patients diagnosed with periampullary neoplasms underwent either RPD (n = 81) or OPD (n = 112). To account for potential selection bias, propensity score matching (PSM) was used to balance patient demographics and clinical characteristics, resulting in two well-matched groups of 60 patients each. Perioperative outcomes, CR-PF rates, and a comprehensive cost analysis were evaluated. RESULTS: RPD resulted in a significantly lower rate of CR-PF (10%) compared to OPD (33.3%) (p = 0.003). Additionally, patients who underwent RPD experienced shorter hospital stays (15 days) compared to those in the OPD group (22.5 days) (p < 0.001). Despite longer operative times for RPD (633 vs. 395 min; p < 0.001), total hospital costs were comparable between the two groups. The higher operative costs associated with RPD were offset by reduced postoperative complications and shorter hospitalization. CONCLUSIONS: RPD offers significant clinical advantages, including lower CR-PF rates and reduced hospital stays, without increasing overall hospital costs compared to OPD. These findings support the feasibility and potential benefits of adopting RPD for the management of periampullary neoplasms in clinical practice.
引用
- Wakabayashi T, Gaudenzi F, Nie Y, et al. Reduced pancreatic fistula rates and comprehensive cost analysis of robotic versus open pancreaticoduodenectomy. Surg Endosc. 2025. PMID: 40355734. doi:10.1007/s00464-025-11768-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。